Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Number of holders
-
271
-
Total 13F shares, excl. options
-
106,503,991
-
Shares change
-
+1,378,624
-
Total reported value, excl. options
-
$4,877,881,469
-
Value change
-
+$56,105,064
-
Put/Call ratio
-
56%
-
Number of buys
-
138
-
Number of sells
-
-117
-
Price
-
$45.82
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q4 2022
326 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q4 2022.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 106,503,991 shares
of 119,358,581 outstanding shares and own 89% of the company stock.
Largest 10 shareholders include BlackRock Inc. (14,967,317 shares), FMR LLC (13,359,958 shares), VANGUARD GROUP INC (10,073,094 shares), WELLINGTON MANAGEMENT GROUP LLP (6,542,724 shares), STATE STREET CORP (5,044,914 shares), LORD, ABBETT & CO. LLC (2,924,311 shares), Polar Capital Holdings Plc (2,724,777 shares), RTW INVESTMENTS, LP (2,574,198 shares), PFM Health Sciences, LP (2,399,545 shares), and PICTET ASSET MANAGEMENT SA (2,265,312 shares).
This table shows the top 271 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.